Jim Cramer Blog

Gilead Sciences (NasdaqGS: GILD):' ... at $81 - a nice little pullback.'Celgene (NasdaqGS: CELG): ' ... has not only not let us down, but now has a cure for the heartbreak of psoriasis.'Patterson-UTI Energy (NasdaqGS: PTEN): 'PTEN is a land driller and, I think, has room to catch up to King Halliburton.'Halliburton (NYSE: HAL - News)Saks (NYSE: SKS - News): 'If you add the $8 in dividends, plus the appreciation, we almost have a double right here. Let the stock come in ... I was not concerned about the gross margins. I think it's a chance to buy, but we only double down when things have been cut, and cut, and cut. You do a schnitzel, my friend, not a full buy.'Schering-Plough (NYSE: SGP - News): 'I should have taken half off, and let the rest run. My advice to you, to take half off and let the rest run. This stock's a double, but it's still going up.'BP (NYSE: BP - News): ' BP, with a 3+% yield... BP, with still some good properties, with the possibility that they're restructuring... I say you pull the trigger right here.'Cisco (NasdaqGS: CSCO): ''Lets just stick with Cisco.It's down three straight points. That's the better... I like best of breed.'RadioShack (NYSE: RSH - News): ' ... give Julian Day the benefit of the doubt. He's the CEO ... He's rationalizing the stores... He is making it so it's a profitable enterprise. The answer is: Stay long!'
Bearish calls:
RH Donnelley (NYSE: RHD - News): 'It's been too high. I've watched the private equity rumor, over and over again. There's been too much hype in the name... I want to sell RHD.'Geron (NasdaqGM: GERN):'Stem cell speculation... Not for me. Sell, sell, sell! I don't want to come near it. It's up too high.'Tellabs (NasdaqGS: TLAB): 'TLAB's was one of the worst quarters I have heard.'Marvell Technology (NasdaqGS: MRVL): ' ... when you look at a stock like MRVL, I bought it... What was I doing? The financials weren't clean. There is a sign on my desk... and what it says is... Accounting irregularities equals sell. Did I look at that before I bought the stock? I did not.'Sally Beauty Holdings (NYSE: SBH - News): 'It's a 'don't buy, don't buy...' I didn't like their quarter. I did take a hard look at it though.'Crystallex (AMEX: KRY - News): 'No. Chavez don't give a darn about his people... sell, sell, sell! I want you out of that stock now. Enough with him. Enough with that country, unless they come around to our ways.'SunPower (NasdaqGM: SPWR)
Published by SeekingAlpha

Labels: BP, CELG, GERN, GILD, HAL, Jim Cramer, KRY, Lightning Round, MRVL, PTEN, RHD, RSH, SBH, SGP, SKS, SPWR, TLAB

Wall Street advanced on Wednesday, with the Dow Jones industrials pushing past its record close as Asian markets recovered from a selloff and investors sifted through a barrage of corporate profit reports.
Investors breathed a bit easier after Asian markets staged a recovery overnight, soothing concerns the region was in jeopardy of slipping into an economic crisis. The Thai government on Tuesday backed off a plan to impose capital controls on foreign investors.
Investors viewed a strong report from automobile dealership chain CarMax Inc. as a boost to the automotive industry. However, transports were lower after FedEx Corp. forecast third-quarter earnings that trailed Wall Street projections.
The advance comes a day after investors overcame lackluster figures on inflation to send the Dow to its 21st record close since the start of October.

Labels: ERIC, FDX, KMX, KOSN, PANC, pfe, RBAK, SBH, TCO

Biopure Corp. (NASDAQ:BPUR - News) said that the U.S. Navy is in discussions with the Food and Drug Administration over potential protocol revisions to its previously proposed Resus Phase IIb/III pre-hospital trauma trial of Hemopure. The talks could enable Resus to proceed as a smaller, Phase II trial, subject to FDA approval, the company said. Last week, the FDA Blood Products Advisory Committee voted 11 to 8, with one abstention, against proceeding with the trial. The Naval Medical Research Center is sponsoring Resus.
Chaparral Steel Co. (NASDAQ:CHAP - News) reported second-quarter earnings of $1.40 a share, nearly double the 72 cents of the year-earlier period.
Cintas Corp. (NASDAQ:CTAS - News) second-quarter net income rose to 51 cents a share from 46 cents in the year-earlier period. Analysts had expected 52 cents.
CPI Corp. (NYSE:CPY - News) narrowed its third-quarter net loss to 15 cents a share from 39 cents in the year-earlier period. Shares outstanding fell to 6.4 million from 7.9 million.
Dell Inc. (NASDAQ:DELL - News), the world's No. 2 computer maker, named Donald Carty vice chairman and chief financial officer. The change of CFO comes amid an investigation of its financial reporting.
FedEx Corp. (NYSE:FDX - News) said Wednesday its second-quarter net income rose 8% to $511 million, to $1.64 a share, from $471 million, or $1.53 a share in the year-earlier period. Excluding costs for a new pilot labor contract at FedEx Express, the company said it would have earned $1.89 a share. Total revenue at the Memphis, Tenn.-based package delivery giant rose 10% in the three months ended Nov. 30 to $8.93 billion from $8.09 billion. Analysts polled by Thomson First Call forecast earnings, on average, of $1.76 a share and $8.91 billion in revenue. FedEx tightened its 2007 earnings outlook to $6.35 to $6.65 a share, or $6.60 to $6.90 a share, excluding labor contract costs. Third-quarter earnings would be $1.20 to $1.35 a share and fourth-quarter earnings are forecast at $1.98 to $2.13 a share.
Forrester Research Inc. (NASDAQ:FORR - News) said Warren Hadley, chief financial officer and treasurer, resigned. The resignation is due to irregularities uncovered by an internal investigation related to an option grant made to Hadley in 1999.
FoxHollow Technologies (NASDAQ:FOXH - News) cut its fourth-quarter revenue-estimate range to $44 million to $46 million from $54 million to $56 million. The Merck & Co. (NYSE:MRK - News) partner said it's reviewing strategy due to slower sales of SilverHawk, a minimally invasive system that removes obstructive plaque and restores blood flow to the legs and feet.
FSI International Inc., (NASDAQ:FSII - News) the maker of equipment used in microelectronics, swung to first-quarter net income of 6 cents a share from a net loss of 14 cents in the year-earlier period.
Greenbrier Companies (NYSE:GBX - News) said it expects its earnings for the first quarter of its fiscal year to fall below expectations, principally due to weaker-than-anticipated results in its North American new railcar manufacturing units. The supplier of equipment and services to the railroad industry said that it expects to report first-quarter to Nov. 30 operating earnings in a range of 10 cents to 13 cents a share. The results for the quarter also include a write-off of loan fees of 4 cents a share and non-cash foreign exchange losses of 3 cents a share. Analysts were expecting the company to post earnings of 54 cents a share for the quarter. The company also said that, in light of the expected first-quarter result, it also doesn't expect to meet its $3.10 to $3.40 fiscal-year earnings per share forecast.
Kohl's Corp. (NYSE:KSS - News) shares were downgraded to neutral by Robert Baird, which cited difficult comparisons and warmer weather hampering fourth-quarter results.
Northfield Laboratories Inc. (NASDAQ:NFLD - News) shares tumbled more after the company reported 46 deaths in a study assessing PolyHeme, compared with 35 deaths in the control group. PolyHeme is a human hemoglobin-based oxygen-carrying red-blood-cell substitute.
Palm (NASDAQ:PALM - News) second-fiscal-quarter earnings fell from the year-earlier result, which was inflated by a tax-accounting measure. Shipments of the company's smart-phone devices continued to grow.
Panacos Pharmaceuticals Inc. (NASDAQ:PANC - News) shares fell 30% after the biotechnology company said preliminary results from the first cohort of a Phase 2b study of bevirimat suggest that the tablet formulation did not deliver the drug as expected.
Park Electrochemical Corp. (NYSE:PKE - News) said that third-quarter net income was $9.5 million, or 47 cents a share, from $9.7 million, or 48 cents a share, a year ago. Analysts had been expecting the materials company to report earnings of 47 cents a share. Sales rose 20% to $68.2 million. The company said that last year's results were flattered by a $1.5 million tax benefit.
ResCare Inc. (NASDAQ:RSCR - News) said it sees per-share earnings of $1.24 to $1.28 in 2007, on revenue of $1.43 billion. Excluding items, ResCare sees per-share earnings of $1.35 to $1.39.
Sally Beauty (NYSE:SBH - News) was cut to underweight from neutral-weight by Prudential Equity Group, which said changes to the company's relationship with cosmetics giant l'Oreal should lower sales by $110 million in the last nine months of fiscal 2007.
Taubman Centers (NYSE:TCO - News) said it expects 2007 funds from operations, a key profitability measure for real estate investment trusts, in the range of $2.73 to $2.78 a share. Analysts surveyed by Thomson First Call are forecasting, on average, FFO of $2.69 a share for 2007. The Bloomfield Hills, Mich., regional shopping-center REIT said it expects 2006 FFO at the upper end of its previous estimate of $2.46 to $2.51 a share.
Tecumseh Products Co. (NASDAQ:TECUA - News) said its third-quarter net loss for the three months ended Sept. 30 widened to $37.8 million, or $2.05 a share, from $37.2 million, or $2.01 a share in the year-ago period. Revenue fell to $429.4 million from $449.9 million. The company cited unfavorable foreign currency fluctuations, higher costs for copper and other commodities, and a writedown of impaired assets. The company expects to take a loss in the fourth quarter because of the same factors cited above.

Labels: BPUR, CHAP, CPY, CTAS, DELL, FDX, FORR, FOXH, FSII, GBX, KSS, MRK, NFLD, PALM, PANC, PKE, RSCR, SBH, TCO, TECUA